Ankylosing Spondylitis Disease Activity Score with CRP (ASDAS-CRP)

Loading...

mg/L

References

  1. Fabio Salvatore Macaluso. The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus.. Autoimmunity reviews, 2024
  2. Wilson Bautista-Molano. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis.. Nature reviews. Rheumatology, 2023
  3. S. Ramiro. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Annals of the Rheumatic Diseases, 2022
  4. Michael M Ward. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.. Arthritis & rheumatology (Hoboken, N.J.), 2019
  5. A. Moltó. An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. Annals of the Rheumatic Diseases, 2017
  6. D. Poddubnyy. High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort. Annals of the Rheumatic Diseases, 2016
  7. Laure Gossec. Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative.. Annals of the rheumatic diseases, 2016
  8. I. Berg. CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up. Annals of the Rheumatic Diseases, 2015
  9. P. Machado. Brief Report: Calculating the Ankylosing Spondylitis Disease Activity Score If the Conventional C‐Reactive Protein Level Is Below the Limit of Detection or If High‐Sensitivity C‐Reactive Protein Is Used: An Analysis in the DESIR Cohort. Arthritis & Rheumatology, 2015
  10. C. Fernández-Espartero. Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Annals of the Rheumatic Diseases, 2013
  11. S. Pedersen. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors. Annals of the Rheumatic Diseases, 2011
  12. S. Pedersen. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor α inhibitors. Annals of the Rheumatic Diseases, 2009
  13. D. Heijde. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases, 2008
  14. C. Lukas. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases, 2008